Downregulation of insulin-like growth factor binding protein 3 and 5 in nitrofen-induced pulmonary hypoplasia

Elke Ruttenstock1, Takashi Doi, Jens Dingemann

  • 1The Children's Research Centre, Our Lady's Children's Hospital, University College Dublin, Dublin 12, Ireland.

Abstract

Insights

Congenital diaphragmatic hernia (CDH) lung hypoplasia is linked to reduced IGFBP-3 and IGFBP-5 gene expression. This downregulation may disrupt retinoid signaling pathways, impacting fetal lung development in CDH models.

Area of Science:

  • Developmental Biology
  • Genetics
  • Pulmonary Medicine

Background:

  • Congenital diaphragmatic hernia (CDH) is a severe condition characterized by high mortality, primarily due to pulmonary hypoplasia.
  • The retinoid signaling pathway (RSP) is implicated in lung development, with evidence suggesting its inhibition in nitrofen-induced CDH models.
  • The insulin-like growth factor (IGF) system, particularly IGFBP-3 and IGFBP-5, interacts with RSP and is crucial for fetal lung growth.

Purpose of the Study:

  • To investigate the hypothesis that pulmonary IGFBP-3 and IGFBP-5 gene expression levels are downregulated in a nitrofen-induced model of pulmonary hypoplasia.
  • To explore the potential role of IGFBP-3 and IGFBP-5 in the pathogenesis of CDH-related lung development abnormalities.

Main Methods:

  • Pregnant rats were administered nitrofen or olive oil on day 9.5 of gestation.
  • Fetal lungs were harvested at days 18 and 21 for analysis.
  • Pulmonary gene and protein expression of IGFBP-3 and IGFBP-5 were quantified using real-time RT-PCR and immunohistochemistry.

Main Results:

  • Significantly decreased IGFBP-3 mRNA levels were observed in nitrofen-exposed fetal lungs on day 21 compared to controls.
  • Significantly decreased IGFBP-5 mRNA levels were found in nitrofen-exposed fetal lungs on day 18 compared to controls.
  • Immunohistochemistry confirmed reduced IGFBP-3 expression on day 21 and reduced IGFBP-5 immunoreactivity on day 18 in hypoplastic lungs.

Conclusions:

  • Downregulation of IGFBP-3 and IGFBP-5 gene expression is a key feature of the nitrofen-induced CDH model.
  • This downregulation may contribute to pulmonary hypoplasia by interfering with the retinoid signaling pathway.
  • IGFBP-3 and IGFBP-5 represent potential therapeutic targets for managing CDH-related lung development issues.